|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A2460 Batch: A246001
Anifrolumab (Anti-IFNAR1) is a human monoclonal antibody. It is a type I interferon (IFN) receptor antagonist, that blocks the activity of type I interferon. Anifrolumab can be used in research of systemic lupus erythematosus (SLE). MW: 145.5 KD.
| CAS No. | 1326232-46-5 |
|---|---|
| Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| Isotype | Human IgG1 |
| Source | CHO |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
| Shipping | Shipped under low temperature conditions |
| Purity | 99% |
| Protein concentration | 3.31mg/ml |
| Endotoxin Level | <1EU/mg |
| cGAS/STING signalling in macrophages aggravates obliterative bronchiolitis via an IFN-α-dependent mechanism after orthotopic tracheal transplantation in mice [ Clin Transl Med, 2025, 15(5):e70323] | PubMed: 40292672 |
| cGAS/STING signalling in macrophages aggravates obliterative bronchiolitis via an IFN-α-dependent mechanism after orthotopic tracheal transplantation in mice [ Clin Transl Med, 2025, 15(5):e70323] | PubMed: 40292672 |
人間や獣医の診断であるか治療的な使用のためにでない。